Related Experiment Video

Updated: Jun 28, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Transient nutlin-3a treatment promotes endoreduplication and the generation of therapy-resistant tetraploid cells

Hong Shen1, Diarmuid M Moran, Carl G Maki

  • 1Department of Radiation Oncology, University of Chicago, Chicago, Illinois60637, USA.

Cancer Research
|October 17, 2008
PubMed

Insights

Nutlin-3a, an MDM2 antagonist, causes cell cycle arrest and DNA replication in cancer cells. This process generates therapy-resistant tetraploid cells, impacting its use in cancer treatment.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Molecular Oncology

Background:

  • MDM2 negatively regulates p53 tumor suppressor activity.
  • Nutlin-3a inhibits MDM2, stabilizing and activating p53.
  • p53 plays a critical role in cell cycle control and DNA repair.

Purpose of the Study:

  • To investigate the effects of Nutlin-3a on p53 wild-type cancer cells.
  • To determine the mechanism of cell cycle arrest and DNA content changes induced by Nutlin-3a.
  • To evaluate the potential for generating therapy-resistant cells after Nutlin-3a treatment.

Main Methods:

  • Treatment of U2OS and HCT116 cancer cell lines with Nutlin-3a.
  • Flow cytometry analysis to assess DNA content and cell cycle phase.
  • Western blotting to detect p53, p21, pRb, Cyclin B1, Cyclin A, and CDC2 expression.
  • Assessment of endoreduplication and tetraploid clone formation.
  • Evaluation of tetraploid cell resistance to ionizing radiation and cisplatin.

Main Results:

  • Nutlin-3a treatment induced G1 and G2 cell cycle arrest with increased 2N and 4N DNA content.
  • p53 and p21 expression increased, while Cyclin B1, Cyclin A, and CDC2 decreased.
  • Removal of Nutlin-3a led to endoreduplication, where 4N cells re-replicated DNA without mitosis.
  • p53-p21 pathway activation was essential for cell cycle arrest and endoreduplication.
  • Generated tetraploid clones exhibited increased resistance to radiation and cisplatin-induced apoptosis.

Conclusions:

  • Transient Nutlin-3a treatment promotes endoreduplication and generates therapy-resistant tetraploid cells in p53 wild-type cancers.
  • The p53-p21 pathway is crucial for mediating these effects.
  • Findings suggest caution and further investigation are needed for Nutlin-3a's clinical application in cancer therapy.

More Related Videos

Generation of Stable Human Cell Lines with Tetracycline-inducible (Tet-on) shRNA or cDNA Expression09:51

Generation of Stable Human Cell Lines with Tetracycline-inducible (Tet-on) shRNA or cDNA Expression

Published on: March 5, 2013

Related Concept Videos

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...